Coronavirus Live Ask the Expert Webinars
View next
Published on September 17, 2020
Upcoming Webinars
Watching, Waiting and Decision-Making with MPNs
Wednesday 9/23/20 at 12:00 PM Pacific/ 3:00 PM Eastern
In the immortal words of Tom Petty, “the waiting is the hardest part.” When it comes to MPNs, making decisions around when to start a specific treatment are difficult. Join us for this discussion on Wednesday, September 23rd at 12 pm PT/ 3 pm ET.
In this installment of Answers Now: Facing MPNs, patient-advocate host Ruth Fein will talk to Dr. Gabriela Hobbs, Clinical Director of Leukemia Service at Mass General, about the pros and cons of watch and wait. Which factors should be included in the process and how should those factors be weighted? Medical history? Symptoms? Blood numbers? Timed treatments? We’ll also hear from a patient about her experience. Send your questions in ahead of the program to mpn@patientpower.info.
This program is sponsored by Incyte. This organization has no editorial control. It is produced by Patient Power in partnership with the MPN Research Foundation. Patient Power is solely responsible for program content.
The Leading Edge of MPN Treatment
Wednesday 9/30/20 at 1:30 PM Pacific/ 4:30 PM Eastern
The tide of new information can be overwhelming. Join us for our next Answers Now: Facing MPNs program on Wednesday, September 30th at 1:30 pm PT/3:30 pm CT/4:30 pm ET to get a clear, succinct picture of what you need to know.
Our host Ruth Fein, a writer and someone who has lived with MPNs for over twenty years, will talk to Dr. Srdan Verstovsek, Professor of Medicine and a hematologist-oncologist at The University of Texas MD Anderson Cancer Center, about recent research leading to new therapies and new understandings of myeloproliferative neoplasms (MPNS) including detailed information about potential new treatments for essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF). As a number of clinical trials move through Phase Three, there are new therapies and more FDA approvals are on the horizon. There are many new treatment options to get excited about.
Get your questions answered live or send them in ahead of the program to mpn@patientpower.info.
This program is sponsored by Incyte. This organization has no editorial control. It is produced by Patient Power in partnership with the MPN Research Foundation. Patient Power is solely responsible for program content.
Learning About Estrogen Receptor-Positive (ER+) Breast Cancer Treatments
Tuesday 10/6/20 at 1:00 PM Pacific/ 4:00 PM Eastern
What treatments are available for estrogen receptor-positive (ER+) breast cancer patients? Are there breast cancer clinical trials that could help? How can patients manage side effects?
Join us on Tuesday, October 6th, at 1 pm PT/4 pm ET for our next breast cancer Answers Now program. A patient advocate host will discuss ER+ treatments with expert Dr. Erika Hamilton from Sarah Cannon Research Institute. They will be joined by another patient advocate. Send your questions for the expert in advance to breast@patientpower.info.
This program is supported by an educational grant from Daiichi Sankyo. This organization has no editorial control. It is produced by Patient Power and Patient Power is solely responsible for program content.
Past Webinars
Telling Others About My CLL Diagnosis
How do you tell family and friends that you have leukemia? Chronic Lymphocytic Leukemia (CLL) patients often don't "look sick" so it may be hard for your family, friends and co-workers to know what you are going through. How do you help others understand your condition?
Host and CLL patient Michele Nadeem-Baker discussed with social worker Robin Katz from Lurie Cancer Center of Northwestern University communication tips for people living with CLL, and the best way to share details of their condition.
This is a sponsored program where organizations have no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
PV, ET and MF: Experts Explain What to Worry About
Rare blood cancers are tricky for doctors to recognize. So how does a patient begin to wrap their head around such a disease?
In this installment of Facing MPNs Answers Now, Host Ruth Fein, who has had all three types of MPN over the course of 25 years, dove into the three types of myeloproliferative neoplasms: essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). We addressed common questions MPN patients have when they're newly diagnosed and the questions doctors wish people would ask to set themselves up for successful management and self-advocacy over the long term. Watch as our host discussed these issues with Dr. Michael J. Mauro of Memorial Sloan Kettering Cancer Center and Dr. Abdulraheem Yacoub of The University of Kansas Cancer Center.
This program is sponsored by Bristol Myers Squibb. This organization has no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
Cancer In The Workplace: Do I Have To Tell My Boss?
The recent death of Black Panther star Chadwick Boseman from colon cancer shocked the world, including his co-stars and directors. Boseman chose not to disclose his 4 year cancer battle, which included surgeries and chemotherapy. Had his cancer diagnosis and treatments been public, would that have changed his career path? For most of us, whether to share a cancer diagnosis and treatment to our employers is a big decision. What are our legal rights? What happens to our work if we disclose our cancer? What if we choose to keep our health information private?
Dr. Mark Lewis, a practicing Utah oncologist living with cancer, Jill Silverstein, employment and civil rights attorney and Esther Schorr, host and patient advocate, answered questions about cancer and the workplace.
When Is A Stem Cell Transplant Necessary to Treat Myeloma?
Is a stem cell transplant right for me? How and when does a stem cell transplant fit into treating myeloma? With all the new advances in myeloma treatments, are stem cell transplants still performed as often?
Host and 3-time stem cell transplant survivor, Jack Aiello sat down with multiple myeloma expert, Dr. Amrita Krishnan from City of Hope to discuss these questions.
Managing MPN Anxiety During COVID-19
Having a myeloproliferative neoplasm like essential thrombocythemia (ET), polycythemia vera (PV) or myelofibrosis (MF) is anxiety producing enough, now add the stress of COVID-19, and many people find their anxiety is through the roof. Are there ways people can cope with the added stress and find ways to calm down all while still getting the treatment you need?
Host and MPN patient Andrew Schorr discussed these issues with counseling psychologist, Dr. Jim Healy. He knows the MPN perspective all too well because his wife, Madonna has been living with polycythemia vera (PV) for over 10 years.
This program is sponsored by Bristol Myers Squibb. This organization has no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
What's My Risk for MPN Disease Progression?
Triple Negative Breast Cancer Treatment News
What treatments are available for triple negative breast cancer patients? Are there triple negative breast cancer clinical trials that could help? How can patients manage triple negative breast cancer chemo side effects?
Patient advocate host Ricki Fairley discussed triple negative breast cancer treatments with expert Dr. Sara Tolaney from Dana-Farber Cancer Institute about these important treatment questions. Send your questions for the expert in advance to breast@patientpower.info.
This program is supported by an educational grant from Daiichi Sankyo. This organization has no editorial control. It is produced by Patient Power and Patient Power is solely responsible for program content.
Aggressive CLL Treatment Options: Are They Right for Me?
KRAS Lung Cancer Treatment News
What's the latest treatment news for lung cancer patients with the KRAS (Kirsten rat sarcoma viral oncogene homologue) mutation?
Terri Conneran, host and founder of the KRAS Kickers Support Group, WAS joined by lung cancer experts, Dr. Jyoti Patel from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Dr. Jessica Lin from Harvard Medical School.
Managing Side Effects of MPN Treatment
Myeloproliferative neoplasms (MPNs) can have symptoms that reduce quality of life and it’s not uncommon for treatments to have bothersome or even serious side effects that may reduce quality of life. How can you and your doctor work together to manage these?
Host Andrew Schorr talked to MPN experts from The University of Texas MD Anderson Cancer Center, Dr. Naveen Pemmaraju and Physician Assistants Rodney Haltom and Julie Huynh-Lu on the various side effects of MPN treatments and how to get relief. They covered side effects including itching, fatigue, and many more.
This program is sponsored by Incyte. This organization has no editorial control. It is produced by Patient Power and Patient Power is solely responsible for the content.
Part 1: Is There Help for Fatigue and Insomnia from MPN Treatment?
Part 2: MPN Treatment: Managing Itching, Sweating and Bone Pain
CLL Expert: Ask Me Anything!
Do you have chronic lymphocytic leukemia questions to ask? During this CLL Ask The Expert Program, host Andrew Schorr spoke with CLL expert Dr. Richard Furman from Weill Cornell Medicine to answer the latest CLL questions related to treatment and news.
This program is sponsored by AbbVie, Inc., Genentech, Inc. and Adaptive Biotechnologies. These organizations have no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
Part 1: Latest News on BTK Inhibitors for CLL
Part 2: Monitoring CLL: Determining Treatment Plan and MRD Testing
Part 3: Latest CLL Research on Scans, Treatments and 17p Deletion
Exercising Safely During COVID-19
Esther Schorr joined avid runner Kenny Capps, who is living with multiple myeloma, and cancer exercise specialist Cathy Skinner from Thrivors, Inc. They discussed how cancer patients can stay active while in quarantine, online resources and creative at-home objects that can be used for exercise.
New Treatments For Essential Thrombocythemia
Part 1: Essential Thrombocythemia and COVID-19 Complication Risk
Part 2: What Essential Thrombocythemia Treatments Are Available?
Part 3: Current Research on Essential Thrombocythemia
Part 4: Can Diet and Exercise Help Essential Thrombocythemia?
Managing Side Effects of New Myeloma Drugs
Multiple Myeloma patients have more treatment options than ever before but how are side effects and toxicities managed?
Host and patient advocate Cindy Chmielewski talked to Dr. Cesar Rodriguez from Wake Forest Baptist Health and Dr. Natalie S. Callander from the University of Wisconsin School of Medicine and Public Health about new myeloma drugs like belamaf, ide-cel, CAR-T, and selinexor. They also discussed how experts are managing toxicities from these new treatment options.
Part 1: Managing the Side Effects of Blenrep for Myeloma
Part 2: Side Effects of Myeloma Treatment: What is Too Much?
Part 3: Darzalex Faspro: What is it and Does it Have Side Effects?
Part 4: What is Selinexor (Xpovio) and Are There Side Effects?
Part 5: Isatuximab-irfc (Sarclisa) As a Multiple Myeloma Treatment
Breast Cancer Care During COVID-19
Part 1: Is Breast Cancer Treatment Safe During COVID-19?
Part 2: Telemedicine for At-Risk Women with Breast Cancer
Part 3: COVID-19 Positive with Breast Cancer
Part 4: Accessing Breast Cancer Treatment During Coronavirus
Part 5: What’s the Risk of COVID-19 for Breast Cancer Patients?
CLL Patients and COVID-19: What's My Risk?
Part 1: New Study Shows COVID-19 Severity in CLL Patients
Part 2: Should I Get a COVID-19 Vaccine if I have CLL?
Part 3: CLL and COVID-19: Do I Need to Stay Quarantined?
Part 4: COVID-19 Treatments in the News: What’s True?
Part 5: What's My Risk of COVID-19 Reinfection if I Have Antibodies?
Epidermal Growth Factor Receptor (EGFR) Lung Cancer News
Part 1: EGFR Lung Cancer Treatment News
Part 2: What is the First Line Treatment for EGFR-Mutant NSCLC?
Latest News For Treating Pediatric Acute Lymphoblastic Leukemia
Part 1: Treatments for Childhood Acute Lymphoblastic Leukemia
Part 2: Immunotherapy and Chemotherapy for Pediatric ALL
Part 3: Childhood Acute Leukemia: Advice For Parents
Would I Be a Good Candidate for an MPN Clinical Trial?
Part 1: Would I Be A Good Candidate For An MPN Clinical Trial?
CLL Survivors Share their CAR-T Cell Experiences
Andrew Schorr talked to expert Dr. Nitin Jain from the University of Texas MD Anderson Cancer Center. They were joined by patient advocates, David Garcia and Larry Saltzman who shared their own CAR-T cell experiences. The panel also discussed if you can get CAR-T cell therapy during the COVID-19 pandemic.
Polycythemia Vera and Clotting: Does COVID-19 Make Me High Risk?
Expert Advice on Managing Side Effects of Cancer Treatment
Cancer, along with the side effects from treatments, is a formidable foe. Palliative care is a means of managing fatigue, pain, nausea, sleeplessness and more.
Often confused with hospice care, palliative care is finally receiving the attention it deserves. From mitigating side effects to improving overall quality of life, it has become an integral part of cancer care. Dr. Subbiah Ishwaria, a leading expert from the University of Texas MD Anderson Cancer Center, and patient advocate Stacey Tinianov, discussed the benefits of palliative care and explain how to incorporate it into your treatment plan.
Managing the Costs of CLL Treatment
CLL treatment can be expensive, particularly over time and when it's treated like a chronic condition. Is there a benefit to fixed duration therapy? Does it keep costs down? Are there financial resources available to help?
Host Andrew Schorr talked to CLL expert Dr. Thomas Kipps of UC San Diego Moores Cancer Center and Dr. Jennifer A. Woyach of The Ohio State University about where cost concerns come into play when making treatment decisions. They were joined by a patient advocate.
This program is sponsored by AbbVie, Inc. and Genentech, Inc. These organizations have no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content
A Cancer Patient's Guide To Masks
Will COVID-19 Influence CLL Care Long Term?
The recent coronavirus pandemic temporarily disrupted plans for many, but will it shift the thinking of chronic lymphocytic leukemia (CLL) treatment forever? Host and 20+ year CLL patient Andrew Schorr talked to leading expert Dr. Nitin Jain from The University of Texas MD Anderson Cancer Center and Dr. Alexey Danilov from City of Hope along with another long-term CLL survivor.
Although this is a sponsored program, Patient Power maintains editorial control and is solely responsible for the content of this program.
Part 1: Has the Pandemic Changed CLL Treatment Approaches?
Part 2: What CLL Patients on Watch and Wait Need to Know Right Now
Part 3: Clinical Trials Explore Use of BTK Inhibitors in COVID-19
The Future of MPN Research After COVID-19
With the coronavirus pandemic, has research on myeloproliferative neoplasms (MPNs) halted? Are clinical trials still moving forward? For our latest Answers Now program, host and MPN patient Andrew Schorr talked to two MPN researchers, Dr. Naveen Pemmaraju of the University of Texas MD Anderson Cancer Center and Dr. Jeanne Palmer of the Mayo Clinic Arizona.
This program is sponsored by Sierra Oncology. This organization has no editorial control. It is produced by Patient Power in partnership with the MPN Research Foundation. Patient Power is solely responsible for the program content.
An Honest Conversation About Masks and COVID-19
What should you say to others about why you're wearing a mask during this coronavirus pandemic?
Breast cancer survivor Greta Beekhuis was hassled in a store parking lot when she wore a mask to pick up her medicine. Greta shared her story and what she wishes she would have said that day. Lung cancer patient Gina Hollenbeck wore a mask to the gym and then posted a photo of herself on social media, along with her reasoning behind it. She shared her experience about backlash she received.
Social work program manager Harold Dean from UAMS Myeloma Center provided guidance for how, or if, to have those difficult conversations with family, friends, neighbors and people you encounter.
Part 1: Breast Cancer Patient Hassled For Wearing
Mask
Latest Myeloma Treatment News From ASCO
Where can you put 50 years of myeloma patient wisdom to work for you so you or a loved one gets the best care? Where? On Patient Power’s Myeloma Answers Now program, FOUR very experienced patients/support leaders gave their perspectives on myeloma news from ASCO, the world’s largest cancer medical meeting. They explained and took questions on what you should talk to your doctor about.
Part 1: What Does the ENDURANCE Trial Mean for Myeloma Patients?
Part 2: CAR T-Cell Clinical Trial Updates for Myeloma Patients
Part 3: What Does the StaMINA Trial Mean for Myeloma Patients?
Is Financial Help Available If I Lost Income Due to COVID-19?
Navigating the costs of cancer care can be daunting enough but what if you have a change in income due to the coronavirus pandemic? That change in income can impact programs you might be enrolled in like Medicaid and Medicare along with co-pay assistance programs. Andrew Schorr led our Answers Now program as he talked to two leading financial navigators, Dan Sherman and Aimee Hoch, on how to deal with these changes and resources that can help.
This is a sponsored program where organizations have no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
Part 1: How Can I Find a Financial
Navigator
Part 2: Is Financial Help Available for Cancer Patients?
Should I Delay CLL Treatment Because of the Coronavirus Pandemic?
Should you delay CLL treatment because of the coronavirus? Whether this is your first treatment or if you need re-treatment after coming out of remission, this is an important question to get answered! What are the pros and cons of initiating or delaying treatment?
Host and CLL patient advocate Andrew Schorr got the answers from CLL experts Dr. Philip Thompson from the University of Texas MD Anderson Cancer Center and Dr. John Allan from Weill Cornell Medicine. CLL patient advocate Jeff Folloder also joined to share his patient perspective.
This program is sponsored by AbbVie, Inc. and Genentech, Inc. These organizations have no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
Part 1: CLL Retreatment Amidst Coronavirus
Part 2: Is CLL Care Finally Returning to Normal?
COVID-19 Testing for MPN Patients
Myeloproliferative neoplasm patients want to know if they can get tested for COVID-19, if they can trust the test results and if their MPN affects the results. Host and MPN patient Andrew Schorr got the facts from MPN experts, Dr. Brady Stein from Lurie Cancer Center in Chicago and Dr. Ellen Ritchie from Weill Cornell in NYC. They were joined by MPN patient advocate and Dr. Ritchie's patient, Ruth Fein who shared her experience with COVID-19 symptoms.
This program is sponsored by Incyte. This organization has no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
The Latest in Blood and Antibody Tests for COVID-19
We are learning more about antibody tests for COVID-19. Host Andrew Schorr led our follow-up session with noted laboratory science experts Susan Leclair, PhD, and Jim Griffith, PhD.
What's My Current Risk for Coronavirus?
What's the latest data on my risk of getting the coronavirus and the complications that could come from it as a CLL patient? Host Andrew Schorr spoke live with Dr. Matthew Davids from Dana-Farber Cancer Institute about his experience treating patients in Boston. They were joined by CLL patient advocate Michele Nadeem-Baker who shared her patient perspective.
Although this is a sponsored program, Patient Power maintains editorial control and is solely responsible for the content of this program.
Part 1: What’s My Current Risk for
Coronavirus?
Part 2: Does Living With CLL Increase My Risk for Coronavirus?
Cancer and COVID-19, When Will I Be Safe?
Throughout the country, states are “opening up” amidst the coronavirus pandemic. What do cancer patients and other immunocompromised individuals need to know? Andrew Schorr talked to two experts from Sarah Cannon Research Institute at Tennessee Oncology.
Making Sense of New Myeloma Treatments During Coronavirus
Amidst the coronavirus pandemic, new myeloma medicines are still being approved. How do patients and their doctors incorporate these new therapies during this time of telemedicine and adjusted treatment schedules? Dr. Saad Usmani from Levine Cancer Institute and leading patient advocate Jack Aiello joined us to discuss.
This program is sponsored by Sanofi Genzyme. This organization has no editorial control. Patient Power is solely responsible for program content.
What Do MPN Patients Need to Know About COVID-19?
We continue to learn what COVID-19 means for MPN patients from top experts. Two experts from leading centers, Dr. Raajit Rampal from Memorial Sloan Kettering in New York City, and Dr. Srdan Verstovsek from MD Anderson in Houston, answered audience questions and explained the latest research. Michelle Woehrle, from the MPN Research Foundation also joined with an update on resources that can help.
Spirituality, Mindfulness and Gratitude
Two spiritual leaders - Rabbi Jill Zimmerman and Pastor Rodrick Echols - joined us to discuss how to tap into your individual version of spirituality, mindfulness and gratitude as we all face this trying time of the coronavirus pandemic.
Coping With Cancer As a Couple Amidst Coronavirus
Andrew and Esther Schorr and inspiring couple Mark Silverstein and Nelia Pacheco joined us for a discussion centered around coping amid coronavirus. Two patients and their spouses compare strategies and took audience questions.
How Do Women of Color With Breast Cancer Cope Now?
Women of color who are diagnosed with breast cancer have poorer access to appropriate care and higher mortality. Now there are many additional challenges because of the effects of the coronavirus pandemic. What are some tips, resources and solutions to help? Two inspiring women who are passionate in their commitment and "in the know," including Maimah Karmo from The TigerLily Foundation and Angela Baker, founder and President of Angel in Disguise, Inc. joined us to offer helpful advice.
Part 1: Disparities in Breast Cancer Care for Women of Color
Part 2: Women of Color With Breast Cancer Advocate for Change
Update on Coronavirus Issues for Multiple Myeloma Patients
Two leading myeloma experts: Dr. Noopur Raje (Mass General) and Dr. Faith Davies (NYU), joined us for another live question-and-answer discussion about issues of concern to myeloma patients and their loved ones.
Dealing With Cancer Financial Worries Due to Coronavirus
Navigating the costs of cancer care can be daunting enough without the added concerns that come with a pandemic that impacts employment, insurance, and many other critical financial factors. Two leading financial guidance and support experts, Dan Sherman - Financial Navigator, The Navectis Group and Ayesha Azam - Patient Access Network Foundation joined us to discuss ways to help get through the complexities of healthcare in the time of coronavirus and share tips and resources.
Cancer Blood Work Tests and Coronavirus
Is your ability to get a monitoring blood test on your regular schedule disrupted? If so, is that a big deal? Would you be able to get a coronavirus or antibody test? How reliable would they be for you to make sound decisions? Two noted laboratory science experts, Susan Leclair, PhD and Jim Griffith, PhD, took audience questions about blood testing and infection surveillance.
Coping With Cancer and Coronavirus Anxiety
Being a cancer patient/survivor has its own set of worries and ongoing concerns about our current health and future wellness. This pandemic only heightens that anxiety. What can you do to help lessen anxiety and deal with the added stress of the current COVID-19 situation? Join us as two specialists: Eucharia Borden, MSW, LCSW, OSW-C - Senior Director, Clinical Services, Cancer Support Community and Jennifer Abraham (Zarou), LCSW, MSW, family therapist and patient advocate, discuss ways we can reduce and control the impact of this stressful time.
How Can Telemedicine Help You Now?
Are you scared to go to your doctor now? Can they "come to you" on the phone or online? Yes! But how does this work and give you confidence. Leading hematologist/oncologist Dr. Mike Thompson (Vince Lombardi Cancer Clinic, Aurora Health Care) discussed how telemedicine is being used in the time of the coronavirus crisis.
Coronavirus: Separating Fact From Fiction for CLL Patients
Can cancer medicines be used to treat COVID-19? Does the effect of the virus vary by CLL subtype? Is ibrutinib (Imbruvica) being mixed with Coca-Cola? Watch to hear expert perspectives on questions like these and more.
With much misinformation circulating online, Dr. Wierda, Professor and Medical Director for the Department of Leukemia at MD Anderson Cancer Center and Dr. Kerry Rogers, from The James Comprehensive Cancer Center at OSU, joined Patient Power to help chronic lymphocytic leukemia patients separate fact from fiction and explain how care is being modified during the pandemic.
Coronavirus and MPN Internet Myths
MPN expert Dr. Laura Michaelis, Associate Professor Hematology/Oncology at the Medical College of Wisconsin, and Dr. Joseph Scandura, Physician Scientist and Associate Professor of Medicine, Scientific Director of the Richard T. Silver, M.D. Myeloproliferative Neoplasms Center; Weill Cornell Medicine, joined us to discuss myths and truths about the impact of the coronavirus on MPN patients.
Melanoma Concerns: Am I at Risk During the Coronavirus Crisis?
Melanoma specialist Dr. Sapna Patel, Associate Professor, Department of Melanoma Medical Oncology at MD Anderson, and Shelby Moneer, MS, CHES Education Director from the Melanoma Research Foundation, joined us as they help us sort through issues and concerns melanoma patients have during the coronavirus crisis. Please send questions in advance to comments@patientpower.info
What Should Acute Leukemia Patients Know About the Coronavirus?
Two leading experts from MD Anderson, Houston - Dr. Tapan Kadia and Dr. Naval Daver - joined us to discuss the issues and concerns patients and loved ones dealing with acute types of leukemia might have in the current coronavirus crisis.
Lung Cancer Trials in the Time of the Coronavirus Crisis
Expert Dr. Sandip Patel (UCSD) joined us to discuss clinical trials for lung cancer patients and what impact the coronavirus may have on these important research programs.
How Will the Coronavirus Affect CLL Treatment?
Dr. Nicole Lamanna (Associate Clinical Professor of Medicine, Columbia University Medical Center) joined us for our second live CLL Ask the Expert program to discuss issues and concerns related to the coronavirus.
CML Expert Discusses How to Protect Yourself From Coronavirus
CML specialist Dr. Michael Mauro (Memorial Sloan Kettering Cancer Center) joined us to issues and concerns about the coronavirus.
Are Myeloma Treatment Plans Changing During Coronavirus?
Dr. Robert Orlowski, Director of Myeloma at MD Anderson, Houston joined us to discuss issues and concerns about the coronavirus as it may impact myeloma patients and survivors.
Navigating Lymphoma Care During COVID-19
Dr. Joshua Brody, from Mount Sinai Health System, joined us to address issues and concerns of lymphoma patients and care partners related to the impact of the coronavirus.
Coronavirus Precautions for Prostate Cancer Patients
Prostate cancer expert Dr. Eleni Efstathiou, from MD Anderson Cancer Center, joined us to discuss questions and concerns about the coronavirus impact on prostate cancer patients.
Coronavirus and What Do Lung Cancer Patients Need to Know
Lung cancer expert Dr. Ross Camidge from the University of Colorado Cancer Center joined us to answer questions about the issues and concerns lung cancer patients and their loved ones have about the coronavirus.
What Are the COVID-19 Risks for MPN Patients?
MPN experts Dr. Ruben Mesa and Dr Robyn Scherber joined us to discuss issues and concerns arising from the coronavirus pandemic specifically for MPN patients.
COVID-19 Outbreak: Breast Cancer Coronavirus Questions Answered
Breast cancer expert Dr. Julie Gralow, from the University of Washington and Seattle Cancer Care Alliance, joined us to discuss issues and concerns that could impact breast cancer patients during this pandemic.
MPNs and Coronavirus: Expert Advice for Patients
Are MPN patients at higher risk for complications? Should we be tested earlier? Do we have to worry about receiving refills of our medicines, are supplies disrupted? We’ll tackle these questions and more with Dr. Naveen Pemmaraju, MD from MD Anderson Cancer Center.
Families Coping With the Coronavirus Health Crisis
Jennifer Abraham is a licensed family therapist, a high-risk CLL patient and a single mom with two teenager daughters. With young people at home and the stress of her own cancer worries, how is she coping, and what advice does she have for you? She welcomes your questions and your own tips we can share!
Your Questions, Expert Answers: Managing Myeloma During the Coronavirus Outbreak
If you are receiving infusions of myeloma medicines, is coming to the clinic risky? Should a treatment plan be changed? Do the medicines diminish immunity? Two experts took questions: Nina Shah, MS, UC San Francisco, and Larry Anderson, MD, UT Southwestern Medical Center in Dallas.
How Can CLL Patients Minimize Their Risk of Exposure to Coronavirus?
Rather than CLL being the “good” cancer to have, are CLL patients especially at higher risk for serious complications from coronavirus? If so, what should we do? Guests included two CLL specialists: Justin Taylor, MD, Memorial Sloan-Kettering in New York City, and Farrukh Awan, MD, UT Southwestern Medical Center in Dallas.
